A retrospective pooled analysis assessing the effect of age on the immunogenicity of Havrix™ in healthy adults

References

• World Health Organization, Department of Communicable Disease Surveillance and Response. Hepatitis A. 2000. Available at http://www.who.int/csr/disease/hepatitis/HepatitisA_whocdscsredc2000_7.pdf?ua=1. Accessed on August 14, 2014.
   Google Scholar
• Franco E, Meleleo C, Serino L, Sorbara D, Zaratti L. Hepatitis A: Epidemiology and prevention in developing countries. World J Hepatol 2012; 4:68-73; PMID:22489258; http://dx.doi.org/10.4254/wjh.v4.i3.68
   PubMedGoogle Scholar
• Van Herck K, Crasta PD, Messier M, Hardt K, Van Damme P. Seventeen-year antibody persistence in adults primed with two doses of an inactivated hepatitis A vaccine. Hum Vaccin Immunother 2012; 8:323-7; PMID:22327499; http://dx.doi.org/10.4161/hv.18617
   PubMed Web of Science ®Google Scholar
• Wasley A, Fiore A, Bell BP. Hepatitis A in the era of vaccination. Epidemiol Rev 2006; 28:101-11; PMID:16775039; http://dx.doi.org/10.1093/epirev/mxj012
   PubMed Web of Science ®Google Scholar
• Vaughan G, Goncalves Rossi LM, Forbi JC, de Paula VS, Purdy MA, Xia G, Khudyakov YE. Hepatitis A virus: host interactions, molecular epidemiology and evolution. Infect Genet Evol 2014; 21:227-43; PMID:24200587; http://dx.doi.org/10.1016/j.meegid.2013.10.023
   PubMed Web of Science ®Google Scholar
• Wu D, Guo CY. Epidemiology and prevention of hepatitis A in travelers. J Travel Med 2013; 20:394-9; PMID:24165384; http://dx.doi.org/10.1111/jtm.12058
   PubMed Web of Science ®Google Scholar
• Genton B, D'Acremont V, Furrer H-J, Hatz C, Louis L. Hepatitis A vaccines and the elderly. Travel Med Infect Dis 2006; 4:303-12; PMID:17098625; http://dx.doi.org/10.1016/j.tmaid.2005.10.002
   PubMedGoogle Scholar
• Nelson NP, Murphy TV, McMahon BJ. Hepatitis A vaccination for post-exposure prophylaxis in persons aged 40 years and older. Vaccine 2014; 32:2939; PMID:24530928; http://dx.doi.org/10.1016/j.vaccine.2014.01.086
   PubMed Web of Science ®Google Scholar
• Van Herck K, Van Damme P. Prevention of hepatitis A by Havrix: a review. Expert Rev Vaccines 2005; 4:459-71; PMID:16117704; http://dx.doi.org/10.1586/14760584.4.4.459
   PubMed Web of Science ®Google Scholar
• Innis BL, Snitbhan R, Kunasol P, Laorakpongse T, Poopatanakool W, Kozik CA, Suntayakorn S, Suknuntapong T, Safary A, Tang DB, et al. Protection against hepatitis A by an inactivated vaccine. JAMA 1994; 271:1328-34; PMID:8158817; http://dx.doi.org/10.1001/jama.1994.03510410040030
   PubMed Web of Science ®Google Scholar
• Rendi-Wagner P, Korinek M, Winkler B, Kundi M, Kollaritsch H, Wiedermann U. Persistence of seroprotection 10 years after primary hepatitis A vaccination in an unselected study population. Vaccine 2007; 25:927-31; PMID:17005304; http://dx.doi.org/10.1016/j.vaccine.2006.08.044
   PubMed Web of Science ®Google Scholar
• Collier MG, Khudyakov YE, Selvage D, Adams-Cameron M, Epson E, Cronquist A, Jervis RH, Lamba K, Kimura AC, Sowadsky R, et al. Outbreak of hepatitis A in the USA associated with frozen pomegranate arils imported from Turkey: an epidemiological case study. Lancet Infect Dis 2014; 14:976-81; PMID:25195178; http://dx.doi.org/10.1016/S1473-3099(14)70883-7
   PubMed Web of Science ®Google Scholar
• Nordic Outbreak Investigation Team C. Joint analysis by the Nordic countries of a hepatitis A outbreak, October 2012 to June 2013: frozen strawberries suspected. Euro Surveill 2013; 18; PMID:23870076
   PubMedGoogle Scholar
• Guzman-Herrador B, Jensvoll L, Einoder-Moreno M, Lange H, Myking S, Nygard K, Stene-Johansen K, Vold L. Ongoing hepatitis A outbreak in Europe 2013 to 2014: imported berry mix cake suspected to be the source of infection in Norway. Euro Surveill 2014; 19; PMID:24762662
   PubMedGoogle Scholar
• Update: Prevention of hepatitis A after exposure to hepatitis A virus and in international travelers. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2007; 56:1080-4; PMID:17947967
   PubMedGoogle Scholar
• World Health Organization. Hepatitis A vaccines – July 2012. Available at http://www.who.int/immunization/position_papers/PP_hep_A_july2012_summary.pdf. Accessed on August 14, 2014.
   Google Scholar
• World Health Organization. The Immunological Basis for Immunization Series. 2011. Available at http://whqlibdoc.who.int/publications/2011/9789241501422_eng.pdf. Accessed on August 14, 2014.
   Google Scholar
• European Centre for Disease Prevention and Control. Euro Surveill 2006; 11. Available at http://www.eurosurveillance.org/images/dynamic/EQ/v06n01/v06n01.pdf. Accessed on August 14, 2014
   Google Scholar
• Canada Communicable Disease Report. A review of provin-cial/territorial strategies for Hepatitis A pre- and post-exposureprophylaxis. 2005. Available at http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/05vol31/dr3119b-eng.php. Accessed on August 20, 2014.
   Google Scholar
• Public Health Agency of Canada. Canadian Immunization Guide. 2012. Available at http://www.phac-aspc.gc.ca/publicat/cig-gci/p04-hepa-eng.php#post. Accessed on August 14, 2014.
   Google Scholar
• Department of Health, Australian Government. The Australian Immunisation Handbook. 2013. Available at http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/5-1. Accessed on August 17, 2014
   Google Scholar
• Communicable Diseases Network of Australia. Hepatitis A – series of national guidelines – guidelines for public health units. 2009. Available at http://www.health.gov.au/internet/main/publishing.nsf/Content/cdna-song-hepa.htm. Accessed on August 20, 2014.
   Google Scholar
• Freeman E, Lawrence G, McAnulty J, Tobin S, MacIntyre CR, Torvaldsen S. Field effectiveness of hepatitis A vaccine and uptake of post exposure prophylaxis following a change to the Australian guidelines. Vaccine 2014; 32:5509-13; PMID:25111168; http://dx.doi.org/10.1016/j.vaccine.2014.07.048
   PubMed Web of Science ®Google Scholar
• McMahon BJ, Beller M, Williams J, Schloss M, Tanttila H, Bulkow L. A program to control an outbreak of hepatitis A in Alaska by using an inactivated hepatitis A vaccine. Arch Pediatr Adolesc Med 1996; 150:733-9; PMID:8673200; http://dx.doi.org/10.1001/archpedi.1996.02170320079014
   PubMed Web of Science ®Google Scholar
• Prikazsky V, Olear V, Cernoch A, Safary A, Andre FE. Interruption of an outbreak of hepatitis A in two villages by vaccination. J Med Virol 1994; 44:457-9; PMID:7897381; http://dx.doi.org/10.1002/jmv.1890440427
   PubMedGoogle Scholar
• Craig AS, Sockwell DC, Schaffner W, Moore WL, Jr., Skinner JT, Williams IT, Shaw FE, Shapiro CN, Bell BP. Use of hepatitis A vaccine in a community-wide outbreak of hepatitis A. Clin Infect Dis 1998; 27:531-5; PMID:9770153; http://dx.doi.org/10.1086/514700
   PubMed Web of Science ®Google Scholar
• Kaic B, Borcic B, Ljubicic M, Brkic I, Mihaljevic I. Hepatitis A control in a refugee camp by active immunization. Vaccine 2001; 19:3615-9; PMID:11395194; http://dx.doi.org/10.1016/S0264-410X(01)00103-7
   PubMed Web of Science ®Google Scholar
• Irwin DJ, Millership S. Control of a community hepatitis A outbreak using hepatitis A vaccine. Commun Dis Public Health 1999; 2:184-7; PMID:10491872
   PubMedGoogle Scholar
• Bonanni P, Colombai R, Franchi G, Lo Nostro A, Comodo N, Tiscione E. Experience of hepatitis A vaccination during an outbreak in a nursery school of Tuscany, Italy. Epidemiol Infect 1998; 121:377-80; PMID:9825788; http://dx.doi.org/10.1017/S0950268898001411
   PubMed Web of Science ®Google Scholar
• Bonanni P, Franzin A, Staderini C, Pitta M, Garofalo G, Cecconi R, Santini MG, Lai P, Innocenti B. Vaccination against hepatitis A during outbreaks starting in schools: what can we learn from experiences in central Italy? Vaccine 2005; 23:2176-80; PMID:15755590; http://dx.doi.org/10.1016/j.vaccine.2005.01.044
   PubMed Web of Science ®Google Scholar
• Shen YG, Gu XJ, Zhou JH. Protective effect of inactivated hepatitis A vaccine against the outbreak of hepatitis A in an open rural community. World J Gastroenterol 2008; 14:2771-5; PMID:18461664; http://dx.doi.org/10.3748/wjg.14.2771
   PubMed Web of Science ®Google Scholar
• Health Protection Agency. Guidance for the Prevention and Control of Hepatitis A Infection. 2009. Available at http://webarchive.nationalarchives.gov.uk/20140714084352/http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1259152095231. Accessed on Decemeber 17, 2014.
   Google Scholar
• Health Protection Agency. Immunoglobulin Handbook. 2009. Available at http://webarchive.nationalarchives.gov.uk/20140714084352/http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1194947366684. Accessed on Decemeber 17, 2014.
   Google Scholar
• National Institute for Public Health and the Environment MoH, Welfare and Sports, Nederlands. LCI-richtlijn Hepatitis A. 2013:1–13. Available at http://www.rivm.nl/Documenten_en_publicaties/Professioneel_Praktisch/Richtlijnen/Infectieziekten/LCI_richtlijnen/LCI_richtlijn_Hepatitis_A. Accessed on August 20, 2014.
   Google Scholar
• Schmidtke P, Habermehl P, Knuf M, Meyer CU, Sanger R, Zepp F. Cell mediated and antibody immune response to inactivated hepatitis A vaccine. Vaccine 2005; 23:5127-32; PMID:16054733; http://dx.doi.org/10.1016/j.vaccine.2005.06.022
   PubMed Web of Science ®Google Scholar
• Findor JA, Canero Velasco MC, Mutti J, Safary A. Response to Hepatitis A Vaccine in Children after a Single Dose with a Booster Administration 6 Months Later. J Travel Med 1996; 3:156-9; PMID:9815444; http://dx.doi.org/10.1111/j.1708-8305.1996.tb00730.x
   PubMedGoogle Scholar
• Dakic Z, Musa S. Hepatitis A outbreak in Bijeljina, Bosnia and Herzegovina, August 2012 - April 2013. Euro Surveill 2013; 18; PMID:23725978
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. Multistate outbreak of hepatitis A virus infections linked to pomegranate seeds from Turkey (Final Update). 2013. Available at http://www.cdc.gov/hepatitis/Outbreaks/2013/A1b-03-31/index.html. Accessed on August 14, 2014.
   Google Scholar
• Rizzo C, Alfonsi V, Bruni R, Busani L, Ciccaglione A, De Medici D, Di Pasquale S, Equestre M, Escher M, Montano-Remacha M, et al. Ongoing outbreak of hepatitis A in Italy: preliminary report as of 31 May 2013. Euro Surveill 2013; 18; PMID:23870075
   PubMedGoogle Scholar
• Van Herck K, Van Damme P. Inactivated hepatitis A vaccine-induced antibodies: follow-up and estimates of long-term persistence. J Med Virol 2001; 63:1-7; PMID:11130881; http://dx.doi.org/10.1002/1096-9071(200101)63:1%3c1::AID-JMV1000%3e3.0.CO;2-U
   PubMed Web of Science ®Google Scholar
• Briem H, Safary A. Immunogenicity and safety in adults of hepatitis A virus vaccine administered as a single dose with a booster 6 months later. J Med Virol 1994; 44:443-5; PMID:7897378; http://dx.doi.org/10.1002/jmv.1890440424
   PubMed Web of Science ®Google Scholar
• Paganelli R, Scala E, Quinti I, Ansotegui IJ. Humoral immunity in aging. Aging (Milan, Italy) 1994; 6:143-50; PMID:7993921
   PubMedGoogle Scholar
• Joines RW, Blatter M, Abraham B, Xie F, De Clercq N, Baine Y, Reisinger KS, Kuhnen A, Parenti DL. A prospective, randomized, comparative US trial of a combination hepatitis A and B vaccine (Twinrix) with corresponding monovalent vaccines (Havrix and Engerix-B) in adults. Vaccine 2001; 19:4710-9; PMID:11535321; http://dx.doi.org/10.1016/S0264-410X(01)00240-7
   PubMed Web of Science ®Google Scholar
• Murphy TV, Stephen M, Bell BP. Hepatitis A vaccines. Vaccines. In: Plotkin SA, Orenstein WA, Offit PA (eds) (6th edition): Elsevier Saunders 2013.
   Google Scholar
• Plotkin SA. Vaccines: correlates of vaccine-induced immunity. Clin Infect Dis 2008; 47:401-9; PMID:18558875; http://dx.doi.org/10.1086/589862
   PubMed Web of Science ®Google Scholar
• Connor BA. Hepatitis A vaccine in the last-minute traveler. Am J Med 2005; 118(Suppl 10A):58S-62S; PMID:16271543; http://dx.doi.org/10.1016/j.amjmed.2005.07.018
   PubMedGoogle Scholar
• Wagner G, Lavanchy D, Darioli R, Pecoud A, Brulein V, Safary A, Frei PC. Simultaneous active and passive immunization against hepatitis A studied in a population of travelers. Vaccine 1993; 11:1027-32; PMID:8212822; http://dx.doi.org/10.1016/0264-410X(93)90128-K
   PubMed Web of Science ®Google Scholar
• Irwin DJ, Millership S. Antibody responses to Hepatitis A vaccine in healthy adults. Commun Dis Public Health 2001; 4:139-40; PMID:11525004
   PubMedGoogle Scholar
• Van Damme P, Lievens M, Stoffel M, Nguyen C. Rapid seroconversion rates after first dose of an inactivated hepatitis A vaccine (Havrix 1440™): results of a retrospective analysis. Travel & Epidemics: 3rd European Conference on Travel Medicine, Florence, Italy. 2002: 218. Availbale at http://www.travelmedicine.it/news/ectm3_abstract.pdf. Accessed on August 14, 2014.
   Google Scholar
• Public health control of hepatitis A: memorandum from a WHO meeting. Bull World Health Organ 1995; 73:15-20; PMID:7704922
   PubMed Web of Science ®Google Scholar
• Torner N, Broner S, Martinez A, Tortajada C, Garcia de Olalla P, Barrabeig I, Sala M, Camps N, Minguell S, Alvarez J, et al. Factors associated to duration of hepatitis a outbreaks: implications for control. PLoS One 2012; 7:e31339; PMID:22355358; http://dx.doi.org/10.1371/journal.pone.0031339
   PubMedGoogle Scholar
• Taliani G, Gaeta GB. Hepatitis A: post-exposure prophylaxis. Vaccine 2003; 21:2234-7; PMID:12744848; http://dx.doi.org/10.1016/S0264-410X(03)00138-5
   PubMed Web of Science ®Google Scholar